Bridgeport Pharmaceutical Product Lawyer, California


Timothy Walter Kendall

General Practice
Status:  In Good Standing           Licensed:  30 Years

Chris I Lizza

General Practice
Status:  In Good Standing           Licensed:  29 Years

Kathleen Coulter Maloney

General Practice
Status:  In Good Standing           Licensed:  43 Years

Margaret R Sackrider

General Practice
Status:  Inactive           Licensed:  43 Years

Mary C. Meinhard

Mediation, Arbitration, Personal Injury, Medical Malpractice
Status:  In Good Standing           

Michael John Seng

General Practice
Status:  Suspended           Licensed:  50 Years

Karen Dale Dustman

General Practice
Status:  Inactive           Licensed:  41 Years

Free Help: Use This Form or Call 800-620-0900

Member Representative

Call me for fastest results!
800-620-0900

Free Help: Use This Form or Call 800-620-0900

By submitting this lawyer request, I confirm I have read and agree to the Consent to Receive Messages from all messaging and voice technologies including Email, Text, Phone, Terms of Use, and Privacy Policy. Information provided is not privileged or confidential.


Free Help: Use This Form or Call 800-943-8690

Member Representative

Call me for fastest results!
800-943-8690

Free Help: Use This Form or Call 800-943-8690

By submitting this lawyer request, I confirm I have read and agree to the Consent to Receive Messages from all messaging and voice technologies including Email, Text, Phone, Terms of Use, and Privacy Policy. Information provided is not privileged or confidential.

TIPS

Easily find Bridgeport Pharmaceutical Product Lawyers and Bridgeport Pharmaceutical Product Law Firms. For more attorneys, search all Health Care areas including Medical Products & Devices, Medicare & Medicaid and Other Health Care attorneys.

SAMPLE LEGAL CASES

Conte v. Wyeth, Inc.

... of the drug, on two grounds: (1) Conte could not show that she or her physician relied upon warnings or product labeling disseminated by Wyeth; and (2) a name-brand pharmaceutical manufacturer owes no duty to individuals who take only generic versions of its product. ...

People v. Gann

... (Id. at p. 280.) Concluding that the two codefendants had misled investigators about their sales of large volumes of stock before the company announced that it had been denied approval for a key pharmaceutical product, the government indicted them for 1010 conspiracy to ...

In re Vioxx Class Cases

... Similarly, plaintiffs allege that Merck represented to prescribing physicians (through marketing representatives, product labels, direct-mailed letters, and published ... were as effective and/or safer." Plaintiffs also relied on the declaration of an expert in pharmaceutical economics to ...